| Comparison of drinking water, raw rice and cooking of rice as arsenic exposure routes in three contrasting areas of West Bengal, India D Mondal, M Banerjee, M Kundu, N Banerjee, U Bhattacharya, AK Giri, ... Environmental geochemistry and health 32, 463-477, 2010 | 178 | 2010 |
| Precancerous and non-cancer disease endpoints of chronic arsenic exposure: the level of chromosomal damage and XRCC3 T241M polymorphism M Kundu, P Ghosh, S Mitra, JK Das, TJ Sau, S Banerjee, JC States, ... Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 706 (1 …, 2011 | 45 | 2011 |
| Ganglioside GM2 mediates migration of tumor cells by interacting with integrin and modulating the downstream signaling pathway M Kundu, B Mahata, A Banerjee, S Chakraborty, S Debnath, SS Ray, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1863 (7), 1472-1489, 2016 | 35 | 2016 |
| Arsenic-induced health effects and genetic damage in keratotic individuals: involvement of p53 arginine variant and chromosomal aberrations in arsenic susceptibility S De Chaudhuri, M Kundu, M Banerjee, JK Das, P Majumdar, S Basu, ... Mutation Research/Reviews in Mutation Research 659 (1-2), 118-125, 2008 | 35 | 2008 |
| Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13–stimulated monocytes and A549 lung carcinoma cells S Dhabal, P Das, P Biswas, P Kumari, VP Yakubenko, S Kundu, ... Journal of Biological Chemistry 293 (36), 14040-14064, 2018 | 30 | 2018 |
| TALEN mediated targeted editing of GM2/GD2-synthase gene modulates anchorage independent growth by reducing anoikis resistance in mouse tumor cells B Mahata, A Banerjee, M Kundu, U Bandyopadhyay, K Biswas Scientific reports 5 (1), 9048, 2015 | 28 | 2015 |
| Targeting mitochondria with ClpP agonists as a novel therapeutic opportunity in breast cancer R Wedam, YE Greer, DJ Wisniewski, S Weltz, M Kundu, D Voeller, ... Cancers 15 (7), 1936, 2023 | 19 | 2023 |
| Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis Cancer Research Communications 2 (10), 1144-1161, 2022 | 18 | 2022 |
| Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy M Kundu, YE Greer, JL Dine, S Lipkowitz Cells 11 (23), 3717, 2022 | 10 | 2022 |
| Mitigation of geogenic arsenic bearing groundwaters: assessing the importance of risk substitution arising from waterborne pathogens D Mondal, DA Polya, AK Giri, M Banerjee, A Hegan, L Rodriguez-Lado, ... Proceedings of the 19th Goldscmidt Conference, 21–26 June 2009, Davos …, 2009 | 3 | 2009 |
| Probabilistic risk assessment of groundwater arsenic DA Polya, D Mondal, AK Giri, M BANERJEE, N BANERJEE, ... Geological Society of America Abstracts with Programs 41, 344, 2009 | 1 | 2009 |
| TRAIL-induced cytokine production via NFKB2 pathway promotes neutrophil chemotaxis and immune suppression in triple negative breast cancers M Kundu, YE Greer, A Lobanov, L Ridnour, RN Donahue, Y Ng, ... bioRxiv, 2024.07. 19.604341, 2024 | | 2024 |
| Tumor necrosis factor related apoptosis inducing ligand (TRAIL) induces cytokine release via the alternative NFKB2 pathway in triple negative breast cancer cells (TNBC) and … M Kundu, YE Greer, LA Ridnour, DA Wink, S Lipkowitz Cancer Research 83 (7_Supplement), 2539-2539, 2023 | | 2023 |
| GM2 mediates tumor cell migration and induces EMT through involvement of the integrin signaling machinery and targeting YAP, a major component of the HIPPO signaling pathway M Kundu, B Mahata, A Banerjee, S Debnath, K Biswas Cancer Research 76 (14_Supplement), 5146-5146, 2016 | | 2016 |
| Deciphering the role and elucidating the mechanism of tumor derived gangliosides in tumor cell growth migration invasiveness and metastasis M Kundu Kolkata, 0 | | |
